Speaking to abc11 in 2015, Dr. David Fajgenbaum shares his journey of diagnosis and treatment as a Castleman disease patient and his efforts to find a cure through the Castleman Disease Collaborative Network (CDCN). Learn more at www.cdcn.org.

The Castleman Disease Collaborative Network (CDCN) hosted a webinar on August 29th, 2016 during which Dr Fajgenbaum answered questions from patients about Castleman disease and ongoing Castleman disease research. Learn more at http://www.cdcn.org/news-events/patient-driven-research.

Dr. David Fajgenbaum shares his thoughts on the current status of Castleman Disease research and resources for patients at an ASH meeting for physicians and researchers. The Castleman Disease Collaborative Network (CDCN) hosted "Accelerating Research & Treatment for Castleman Disease" on December 6, 2014 in San Francisco, CA. Learn more at www ...

Dr. Angela Dispenzieri shares her thoughts on the current status of Castleman Disease research and resources for patients at an ASH meeting for physicians and researchers. The Castleman Disease Collaborative Network (CDCN) hosted "Accelerating Research & Treatment for Castleman Disease" on December 6, 2014 in San Francisco, CA. Learn more at ...

Dr. Sunita Nasta shares her thoughts on the current status of Castleman Disease research and resources for patients at an ASH meeting for physicians and researchers. The Castleman Disease Collaborative Network (CDCN) hosted "Accelerating Research & Treatment for Castleman Disease" on December 6, 2014 in San Francisco, CA. Learn more at www ...

David Fajgenbaum, a 32-year-old doctor at the University of Pennsylvania, is racing to find a cure for Castleman disease, an illness that’s “like a mix between an autoimmune disease and a cancer.” Fajgenbaum is not only devoting his life to this cause for other patients – he’s been battling the rare and deadly disease himself since ...

Chris Kimura from Sandy Oak, CA talks about his experiences with multicentric Castleman disease at the first-ever "Beating Castleman's, Together" Patient/Loved one summit, which was hosted by the Castleman Disease Collaborative Network on December 5, 2014. www.castlemannetwork.org

. Chapters 0:00 Introduction 0:53 Symptoms of Castleman Disease 1:58 Causes of Castleman Disease 2:24 diagnosis of Castleman Disease 2:51 Treatment of Castleman Disease Castleman disease is a group of uncommon lymphoproliferative disorders characterized by lymph node enlargement, which often manifests without any other obvious symptoms ...

Dr. David Fajgenbaum presents An Overview of Castleman Disease & An Update on Pathogenesis at an ASH meeting for physicians and researchers. The Castleman Disease Collaborative Network (CDCN) hosted "Accelerating Research & Treatment for Castleman Disease" on December 6, 2014 in San Francisco, CA. Learn more at www.castlemannetwork.org.

Daniel Arenas, from the University of Pennsylvania, Philadelphia, PA, talks about the rare lymphoproliferative disorder Castleman disease at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Meet Castleman disease warrior, Gary, and get a glimpse into his life-threatening battle with Castleman disease. To learn more, please visit the Castleman Disease Collaborative Network: http://www.CDCN.org

In this exclusive interview, Dr. Mikhil Mushni of the Dana-Farber Cancer Institute talks about treatment options for Unicentric and Multicentric Castleman's disease. Unicentric Castleman's disease can usually be treated by surgically removing the lymph node. In Multicentic Castleman's disease, numerous treatments have been attempted but the ...

David Fajgenbaum, MD, MBA, MSc at the Penn Orphan Disease Center, leads the Castleman Disease Research Program at Penn.

Castleman disease is a rare and deadly disease as common as ALS and more deadly than lymphoma. Patients, loved ones, physicians and researchers are working together to find a cure! Here are quick facts about Castleman disease. Visit cdcn.org to learn more.

MANAGEMENT OF CASTLEMAN DISEASE Castleman disease is sometimes referred to as a mix between an autoimmune disease, an infectious disease, and a cancer with symptoms that mimic many other disorders. Because Castleman disease is rare, healthcare professionals often correctly and rightfully suspect other diseases first. Diagnosis of exclusion is a ...

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

While rare, COVID infections can be transmitted from a mother to her baby, causing brain injuries to newborns, according to a new study. UCSF’s Dr. Peter Chin-Hong has some insight.

Visit https://brilliant.org/scishow/ to get started learning STEM for free. The first 200 people will get 20% off their annual premium subscription and a 30-day free trial. Searching for a cure for rickets led to the discovery of vitamin D. Fortifying foods with vitamin D led to another disease, and a whole new way to view genetic disease in ...

A medical association based in Virginia — the Infectious Diseases Society of America (IDSA) — says the U.S. is experiencing a dire shortage of infectious disease specialists. Experts weigh in.

Abdullah Chanin, MD, MSc, is an infectious diseases specialist at Loyola Medicine. He treats infections such as HIV and AIDS, the flu, RSV and COVID-19. He discusses the new technologies that are are becoming available to treat complicated infections. For more information or to schedule an appointment, please visit https://www.loyolamedicine ...

Thomas Uldrick, MD, ‎Staff Clinician at the National Cancer Institute of the National Institutes of Health discusses what baseline measures will help predict outcomes in patients with sarcoma herpesvirus-associated Casteleman's disease. Source Uldrick A, Polizzotto MN, Goncalves P, et al. Outcomes in Kaposi sarcoma herpesvirus-­‐associated ...

Dr. David Fajgenbaum welcomes patients and loved ones to the 2022 Patient and Loved One Summit in Philadelphia, PA and educates community on What is Castleman disease.

Learn all about unicentric Castleman disease from our experts Dr. Eric Oksenhendler, Dr. Josh Brandstadter and Dr. Gordan Srkalovic

UCD treatments, research updates, and symptom management presented at the 2022 Patient and Loved One Summit in Philadelphia, PA

The Castleman Disease Collaborative Network (CDCN) is an international network dedicated to curing Castleman disease and creating a blueprint for curing diseases. Learn more about the CDCN and donate today at: http://www.CDCN.org Our co-founder, Dr. David Fajgenbaum, has his last rites read to him while battling Castleman disease before he ...

Dr. Isaac Bogoch, an infectious diseases specialist at the University Health Network, says people should stick to the basics of hygiene as the future of COVID-19 variants remains uncertain, with variants like BQ.1.1 spreading.

A Coroner's court has ruled that the death of a 43-year-old woman was likely related to a COVID-19 booster jab she took just days before. The State Coroner said she died from an inflammation of the heart, calling it "a medical misadventure". Dr Leong Hoe Nam, an infectious diseases specialist from the Rophi Clinic at Mount Elizabeth Novena ...

Siltuximab is now approved for multicentric Castleman's disease: http://www.targetedonc.com/articles/Siltuximab-Approved-by-FDA-for-Multicentric-Castlemans-Disease For more resources and information on multicentric Castleman's disease, please visit http://www.raredr.com/

Dr. Ahmet Dogan presents Castleman Disease Pathology & Diagnosis at an ASH meeting for physicians and researchers. The Castleman Disease Collaborative Network (CDCN) hosted "Accelerating Research & Treatment for Castleman Disease" on December 6, 2014 in San Francisco, CA. Learn more at www.castlemannetwork.org.

Multicentric Castleman’s disease: a poorly understood lymphoproliferative disorder. Read the full Clinical Picture, Adrenalitis and anasarca in idiopathic multicentric Castleman's disease: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00674-7/fulltext

This interview is an episode from @the-well, our publication about ideas that inspire a life well-lived, created with the @JohnTempletonFoundation. Subscribe to The Well on YouTube https://bit.ly/thewell-youtube Watch Albert-László Barabási’s next interview https://youtu.be/E1eo80fFblM The Human Genome Project was a major breakthrough in ...

CDCN's Community Gathering on Rare Disease Day was hosted by Dr. David Fajgenbaum and Mileva Repasky on Zoom and Facebook live. We were joined by Melanie and Mike, two Castleman disease researchers, to discuss their work to understand altered gene expression programs in CD lymph node tissue to identify new treatments.

The Castleman Disease Collaborative Network (CDCN) is dedicated to accelerating research and treatment for Castleman disease through global collaboration, strategic investments in high impact research, and patient engagement. Learn more about the CDCN at www.castlemannetwork.org Learn more about CD at www.bloodjournal.hematologylibrary.org ...

Infectious diseases specialist Dr. Isaac Bogoch joins CPAC’s Peter Van Dusen to discuss the federal government’s decision to suspend COVID-19 vaccine mandates for domestic travel by plane or train and outgoing international flights.

At the 2014 American Society Clinical Oncology (ASCO) Annual Conference, Sawyer et al presented data looking at lean body mass (LBM) outcomes in patients with multicentric Castleman’s disease who received Sylvant (siltuximab) or placebo in a randomized, double-blind, placebo-controlled study. As Dr Michael Sawyer, Associate Professor, Medical ...

Meet one of our youngest Castleman disease warriors, Katie, and get a glimpse into her everyday battle with Castleman disease. To learn more, please visit the Castleman Disease Collaborative Network: http://www.CDCN.org

NEW Updated video! The Castleman Disease Collaborative Network (CDCN) is an international network dedicated to curing Castleman disease and creating a blueprint for curing diseases. Learn more about the CDCN and donate today at: http://www.CDCN.org Our co-founder, Dr. David Fajgenbaum, has his last rites read to him while battling Castleman ...

Overview Castleman Disease (CD) describes a group of rare lymphoproliferative disorders that involve enlarged lymph nodes with characteristic microscopic changes and a broad range of inflammatory symptoms and laboratory abnormalities..Whether Castleman disease should be considered an autoimmune disease, cancer, or infectious disease is ...

Learn why Johns Hopkins is focused on researching autoimmune diseases such as multiple sclerosis, myositis, scleroderma and rheumatoid arthritis, from the director of the Division of Rheumatology, Dr. Antony Rosen. For more information, visit http://www.hopkinsmedicine.org/fox.

Infectious diseases specialist Dr. Matthew Oughton advises immunocompromised people to take 'Kraken' variant seriously. Subscribe to CTV News to watch more videos: https://www.youtube.com/ctvnews Connect with CTV News: For the latest news visit: http://www.ctvnews.ca/ For a full video offering visit the CTV News Network: http://www.ctvnews.ca ...

Taken from JRE #1979 w/Dr. Aseem Malhotra: https://open.spotify.com/episode/43D9PMFx0j9BdbpcS9meBY?si=90b2b85b819c4f7f

Castleman disease, also known as giant or angiofollicular lymph node hyperplasia, lymphoid hamartoma, angiofollicular lymph node hyperplasia, is a group of uncommon lymphoproliferative disorders that share common lymph node histological features that may be localized to a single lymph node or occur systemically. It is named after Benjamin ...

Infectious disease specialist Dr. Donald Vinh on the small spring resurgence of the flu and cases of the flesh-eating disease.

Infectious diseases specialist Dr. Isaac Bogoch discusses the newest omicron subvariant and what to know about ticks.

A new report reveals gaps in awareness, research, diagnosis and care that are threatening South Asian women heart and brain health. Radhika Sharma speaks with a heart specialist about the risk factors associated with South Asian women.

California officially ends its emergency declaration Tuesday. So, what does that mean? NBC Bay Area’s Raj Mathai spoke to Dr. Peter Chin-Hong of UCSF for some insight on this milestone.

She was an infectious-diseases specialist at Harvard Medical School and Massachusetts General Hospital before President Biden picked her to lead the CDC.

Infectious diseases specialist Dr. Matthew Oughton advises immunocompromised people to take 'Kraken' variant seriously.

Infectious diseases specialist Dr. Isaac Bogoch speaks to CTV's Your Morning about the Marburg virus outbreak in Equatorial Guinea.

As scientists search for a treatment and cure for COVID-19, they're now looking at drugs that have been used to treat other diseases to see how effective they might be against the coronavirus.

Castleman or Castleman's disease is not a cancer but is a lymphoproliferative disorder involving an overgrowth (proliferation) of lymphatic cells. Castleman's disease affects the lymph nodes and may require treatment with surgery, chemotherapy and/or radiation therapy. Castleman's disease is also referred to as giant lymph node hyperplasia, or ...

Ruth-Anne Langan Pai, PhD Candidate and the collaborative research project lead for the Castleman Disease Collaborative Network (CDCN) provides an overview of Castleman disease. Castleman disease is a group of rare disorders characterized by lymph node enlargement, specific microscopic changes to the lymph nodes, and a range of symptoms and ...

With a weekly health update, TMS checks in with infectious diseases specialist Dr. Isaac Bogoch who weighs-in on the latest health headlines, including hospitalizations, drug shortages and long COVID.

With a weekly health update, TMS checks in with infectious diseases specialist Dr. Isaac Bogoch who weighs-in on the latest health headlines, including hospitalizations, drug shortages and long COVID.

For more information about Parkinson’s disease, please visit https://cle.clinic/3ekCJFl How can you slow down the progression of Parkinson’s disease? Learn the numerous benefits of exercise for someone with Parkinson’s disease from neurologist and Parkinson’s disease specialist Tarannum Khan, MD. To learn more about Dr. Khan, please ...

The newest RareConnect community for Castleman disease is introduced along with presentations from patient associations working to cure the disease. Join the Castleman disease community to connect with others around the world: https://www.rareconnect.org/en/community/castleman-disease Castleman Disease (CD) is a rare and poorly-understood ...

Infectious diseases specialist Dr. Isaac Bogoch speaks to CTV's Your Morning about the U.S. FDA proposing an annual COVID-19 shot.

Creatine is an incredibly cheap and effective supplement that doesn't get the attention it deserves. Sure, it's well known in the field of bodybuilding but there are a lot of reasons that just about everyone should consider taking this over-the-counter supplement. Here are 6 studied reasons why you may want to use it: 1. Creatine helps build ...

Dr. David Fajgenbaum, MD, MBA, MSc gave the keynote address at a Medidata Solutions event on January 6, 2016. He speaks about "Overtime," which he believes he has been in ever since he had his last rites read to him in November 2010 while battling idiopathic multicentric Castleman disease. He's fighting to cure the disease for himself and the ...

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/